Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized, Controlled, Blinded Pivotal Study In Subjects Undergoing A Transforaminal Lumbar Interbody Fusion (TLIF) At One Or Two Levels Using Infuse™ Bone Graft With an Intervertebral Body Fusion Device and Posterior Supplemental Fixation For The Treatment Of Symptomatic Degenerative Disease Of The Lumbosacral Spine

NCT04073563 is registered in ClinicalTrials.gov with Medtronic Spinal and Biologics as lead sponsor.

NCT NCT04073563
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04073563 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized, Controlled, Blinded Pivotal Study In Subjects Undergoing A Transforaminal Lumbar Interbody Fusion (TLIF) At One Or Two Levels Using Infuse™ Bone Graft With an Intervertebral Body Fusion Device and Posterior Supplemental Fixation For The Treatment Of Symptomatic Degenerative Disease Of The Lumbosacral Spine
Lead sponsor
Medtronic Spinal and Biologics
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 19, 2019
Completion date
July 31, 2028
Enrollment
600 (estimated)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative disease of the lumbosacral spine